College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Biomed J. 2024 Jun;47(3):100686. doi: 10.1016/j.bj.2023.100686. Epub 2023 Dec 10.
Clostridioides difficile, the etiological agent of C. difficile infection (CDI), elicits a spectrum of diarrheal symptoms with varying severity and the potential to result in severe complications such as colonic perforation, pseudomembranous colitis, and toxic megacolon. The perturbation of gut microbiome, often triggered by antibiotic usage, represents the primary factor augmenting the risk of CDI. This underscores the significance of interactions between C. difficile and the microbiome in determining pathogen adaptability. In recent years, researchers have increasingly recognized the pivotal role played by intestinal microbiota in host health and its therapeutic potential as a target for medical interventions. While extensive evidence has been established regarding the involvement of gut bacteria in CDI, our understanding of symbiotic interactions between hosts and fungi within intestinal microbiota remains limited. Herein, we aim to comprehensively elucidate both composition and key characteristics of gut fungal communities that significantly contribute to CDI, thereby enhancing our comprehension from pharmacological and biomarker perspectives while exploring their prospective therapeutic applications for CDI.
艰难梭菌(Clostridioides difficile)是艰难梭菌感染(CDI)的病原体,可引发一系列不同严重程度的腹泻症状,并有可能导致严重并发症,如结肠穿孔、伪膜性结肠炎和中毒性巨结肠。肠道微生物组的紊乱,通常由抗生素的使用引发,是增加 CDI 风险的主要因素。这凸显了艰难梭菌和微生物组之间的相互作用在决定病原体适应性方面的重要性。近年来,研究人员越来越认识到肠道微生物群在宿主健康中的关键作用及其作为医学干预靶点的治疗潜力。尽管已经有大量证据表明肠道细菌与 CDI 有关,但我们对宿主和肠道微生物群内真菌之间共生相互作用的理解仍然有限。在此,我们旨在全面阐明对 CDI 有重要贡献的肠道真菌群落的组成和关键特征,从而从药理学和生物标志物的角度提高我们的认识,并探索其对 CDI 的潜在治疗应用。